These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31064074)

  • 1. The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response.
    Martelli AM; Paganelli F; Fazio A; Bazzichetto C; Conciatori F; McCubrey JA
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31064074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic PTEN functions and models in T-cell malignancies.
    Tesio M; Trinquand A; Macintyre E; Asnafi V
    Oncogene; 2016 Jul; 35(30):3887-96. PubMed ID: 26616857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
    Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
    Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
    Martelli AM; Lonetti A; Buontempo F; Ricci F; Tazzari PL; Evangelisti C; Bressanin D; Cappellini A; Orsini E; Chiarini F
    Adv Biol Regul; 2014 Sep; 56():6-21. PubMed ID: 24819383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors.
    Lonetti A; Cappellini A; Spartà AM; Chiarini F; Buontempo F; Evangelisti C; Evangelisti C; Orsini E; McCubrey JA; Martelli AM
    Oncotarget; 2015 Apr; 6(12):10399-414. PubMed ID: 25871383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia.
    Guo D; Teng Q; Ji C
    Leuk Lymphoma; 2011 Jul; 52(7):1200-10. PubMed ID: 21463127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
    Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
    PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.
    Steelman LS; Abrams SL; Whelan J; Bertrand FE; Ludwig DE; Bäsecke J; Libra M; Stivala F; Milella M; Tafuri A; Lunghi P; Bonati A; Martelli AM; McCubrey JA
    Leukemia; 2008 Apr; 22(4):686-707. PubMed ID: 18337767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
    Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytes.
    Gon S; Loosveld M; Crouzet T; Potier D; Bonnet M; Morin SO; Michel G; Vey N; Nunès JA; Malissen B; Roncagalli R; Nadel B; Payet-Bornet D
    Haematologica; 2018 Jun; 103(6):999-1007. PubMed ID: 29567770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update.
    Evangelisti C; Chiarini F; McCubrey JA; Martelli AM
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia.
    Schwarzer A; Holtmann H; Brugman M; Meyer J; Schauerte C; Zuber J; Steinemann D; Schlegelberger B; Li Z; Baum C
    Oncogene; 2015 Jul; 34(27):3593-604. PubMed ID: 25241901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD.
    Yuan T; Yang Y; Chen J; Li W; Li W; Zhang Q; Mi Y; Goswami RS; You JQ; Lin D; Qian MD; Calin S; Liang Y; Miranda RN; Calin GA; Zhou X; Ma L; Zweidler-McKay PA; Liu B; Weng AP; Medeiros LJ; Zhang Y; You MJ
    Leukemia; 2017 Nov; 31(11):2355-2364. PubMed ID: 28280276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells.
    Dida F; Li Y; Iwao A; Deguchi T; Azuma E; Komada Y
    Exp Hematol; 2008 Oct; 36(10):1343-53. PubMed ID: 18599181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
    Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
    Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia.
    Bongiovanni D; Saccomani V; Piovan E
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28872614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.